Description

Perrigo Company: How It’s Quietly Winning U.S. Store Brands While Categories Stay Soft!

Perrigo Company delivered a mixed set of results for the third quarter of 2025, reflecting both operational progress and ongoing market headwinds across its key business segments. Management highlighted that the consumer health environment remained soft in both the U.S. and Europe, with declining OTC category consumption influencing overall results. Despite these challenges, Perrigo gained share in multiple OTC categories across both regions, underscoring the resilience of its store brand strategy and the strength of core brands such as ellaOne, Jungle Formula, and Physiomer. The company continued advancing its “Three-S Plan”—to Stabilize, Streamline, and Strengthen—which is designed to reinforce its consumer health positioning through portfolio optimization, operational efficiency, and strategic focus on higher-margin segments. Financially, Perrigo reported third-quarter organic net sales down 4.4%, mainly due to lower OTC consumption and weakness in businesses under review—Infant Formula and Oral Care.